BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37996731)

  • 21. Utility of Serum Biomarkers in the Diagnosis and Stratification of Mild Traumatic Brain Injury.
    Lewis LM; Schloemann DT; Papa L; Fucetola RP; Bazarian J; Lindburg M; Welch RD
    Acad Emerg Med; 2017 Jun; 24(6):710-720. PubMed ID: 28170122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL.
    Chen CH; Cheng YW; Chen YF; Tang SC; Jeng JS
    J Neuroinflammation; 2020 Apr; 17(1):124. PubMed ID: 32321529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Admission levels of serum biomarkers have additive and cumulative prognostic value in traumatic brain injury.
    Kaaber IA; Lesbo M; Wichmann TO; Olsen DA; Rasmussen MM; Brink O; Borris LC; Hviid CVB
    Sci Rep; 2024 Jun; 14(1):14139. PubMed ID: 38898030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.
    Diaz-Arrastia R; Wang KK; Papa L; Sorani MD; Yue JK; Puccio AM; McMahon PJ; Inoue T; Yuh EL; Lingsma HF; Maas AI; Valadka AB; Okonkwo DO; Manley GT;
    J Neurotrauma; 2014 Jan; 31(1):19-25. PubMed ID: 23865516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity.
    Virhammar J; Nääs A; Fällmar D; Cunningham JL; Klang A; Ashton NJ; Jackmann S; Westman G; Frithiof R; Blennow K; Zetterberg H; Kumlien E; Rostami E
    Eur J Neurol; 2021 Oct; 28(10):3324-3331. PubMed ID: 33369818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study.
    Korley FK; Jain S; Sun X; Puccio AM; Yue JK; Gardner RC; Wang KKW; Okonkwo DO; Yuh EL; Mukherjee P; Nelson LD; Taylor SR; Markowitz AJ; Diaz-Arrastia R; Manley GT;
    Lancet Neurol; 2022 Sep; 21(9):803-813. PubMed ID: 35963263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum assessment of traumatic axonal injury: the correlation of GFAP, t-Tau, UCH-L1, and NfL levels with diffusion tensor imaging metrics and its prognosis utility.
    Castaño-Leon AM; Sánchez Carabias C; Hilario A; Ramos A; Navarro-Main B; Paredes I; Munarriz PM; Panero I; Eiriz Fernández C; García-Pérez D; Moreno-Gomez LM; Esteban-Sinovas O; Garcia Posadas G; Gomez PA; Lagares A
    J Neurosurg; 2023 Feb; 138(2):454-464. PubMed ID: 35901687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of hypothermia therapy on serum GFAP and UCH-L1 levels in neonates with hypoxic-ischemic encephalopathy].
    Jiang SH; Wang JX; Zhang YM; Jiang HF
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Dec; 16(12):1193-6. PubMed ID: 25523563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain Injury.
    Papa L; Brophy GM; Welch RD; Lewis LM; Braga CF; Tan CN; Ameli NJ; Lopez MA; Haeussler CA; Mendez Giordano DI; Silvestri S; Giordano P; Weber KD; Hill-Pryor C; Hack DC
    JAMA Neurol; 2016 May; 73(5):551-60. PubMed ID: 27018834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes.
    Lennol MP; Ashton NJ; Moreno-Pérez O; García-Ayllón MS; Ramos-Rincon JM; Andrés M; León-Ramírez JM; Boix V; Gil J; Blennow K; Merino E; Zetterberg H; Sáez-Valero J
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma tau, NfL, GFAP and UCHL1 as candidate biomarkers of alcohol withdrawal-associated brain damage: A pilot study.
    Clergue-Duval V; Vrillon A; Jeanblanc J; Questel F; Azuar J; Fouquet G; Mouton-Liger F; Rollet D; Hispard E; Bouaziz-Amar E; Bloch V; Dereux A; Cognat E; Marie-Claire C; Laplanche JL; Bellivier F; Paquet C; Naassila M; Vorspan F
    Addict Biol; 2022 Nov; 27(6):e13232. PubMed ID: 36301211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical descriptors of disease trajectories in patients with traumatic brain injury in the intensive care unit (CENTER-TBI): a multicentre observational cohort study.
    Åkerlund CAI; Holst A; Bhattacharyay S; Stocchetti N; Steyerberg E; Smielewski P; Menon DK; Ercole A; Nelson DW;
    Lancet Neurol; 2024 Jan; 23(1):71-80. PubMed ID: 37977157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia.
    Ingannato A; Bagnoli S; Mazzeo S; Giacomucci G; Bessi V; Ferrari C; Sorbi S; Nacmias B
    Front Endocrinol (Lausanne); 2024; 15():1375302. PubMed ID: 38654932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of Biostatistical Models to Manage Replicate Error in Concussion Biomarker Research.
    Tabor JB; Galarneau JM; Penner LC; Cooper J; Ghodsi M; Fraser DD; Wellington CL; Debert CT; Emery CA
    JAMA Netw Open; 2023 Oct; 6(10):e2339733. PubMed ID: 37870831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of GFAP and UCH-L1 Measurements Using Two Automated Immunoassays (i-STAT
    Oris C; Khatib-Chahidi C; Pereira B; Bailly Defrance V; Bouvier D; Sapin V
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Umbilical cord blood concentrations of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) in neonates developing hypoxic-ischemic encephalopathy.
    Zaigham M; Lundberg F; Hayes R; Undén J; Olofsson P
    J Matern Fetal Neonatal Med; 2016; 29(11):1822-8. PubMed ID: 26135781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ability of Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and S100B To Differentiate Normal and Abnormal Head Computed Tomography Findings in Patients with Suspected Mild or Moderate Traumatic Brain Injury.
    Welch RD; Ayaz SI; Lewis LM; Unden J; Chen JY; Mika VH; Saville B; Tyndall JA; Nash M; Buki A; Barzo P; Hack D; Tortella FC; Schmid K; Hayes RL; Vossough A; Sweriduk ST; Bazarian JJ
    J Neurotrauma; 2016 Jan; 33(2):203-14. PubMed ID: 26467555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of Early Diagnostic Value of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase Blood Levels in Minor Head Trauma in Turkey.
    Polat ZM; Yucel M; Cikriklar HI; Altındiş M; Yurumez Y
    Clin Lab; 2022 Aug; 68(8):. PubMed ID: 35975499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats.
    Huang XJ; Glushakova O; Mondello S; Van K; Hayes RL; Lyeth BG
    J Neurotrauma; 2015 Aug; 32(16):1179-89. PubMed ID: 25763798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19.
    Kanberg N; Ashton NJ; Andersson LM; Yilmaz A; Lindh M; Nilsson S; Price RW; Blennow K; Zetterberg H; Gisslén M
    Neurology; 2020 Sep; 95(12):e1754-e1759. PubMed ID: 32546655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.